Abstract
Three structural features of lipid A (addition of palmitate [C16 fatty acid], addition of aminoarabinose [positively charged amino sugar residue], and retention of 3-hydroxydecanoate [3-OH C10 fatty acid]) were determined for Pseudomonas aeruginosa isolates from patientswith cystic fibrosis (CF; n = 86), from the environment (n = 13), and from patients with other conditions (n = 14). Among P. aeruginosa CF isolates, 100% had lipid A with palmitate, 24.6% with aminoarabinose, and 33.3% retained 3-hydroxydecanoate. None of the isolates from the environment or from patients with other conditions displayed these modifications. These results indicate that unique lipid A modifications occur in clinical P. aeruginosa CF isolates. © 2007 by the Infectious Diseases Society of America. All rights reserved.
Cite
CITATION STYLE
Ernst, R. K., Moskowitz, S. M., Emerson, J. C., Kraig, G. M., Adams, K. N., Harvey, M. D., … Miller, S. I. (2007). Unique lipid A modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis. Journal of Infectious Diseases, 196(7), 1088–1092. https://doi.org/10.1086/521367
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.